Concepts (160)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trial of Labor | 6 | 2021 | 27 | 2.840 |
Why?
|
| Vaginal Birth after Cesarean | 5 | 2021 | 28 | 2.660 |
Why?
|
| Labor, Induced | 5 | 2017 | 34 | 1.890 |
Why?
|
| Cesarean Section | 8 | 2021 | 367 | 1.860 |
Why?
|
| Patient Care Bundles | 2 | 2020 | 30 | 1.410 |
Why?
|
| Pregnancy | 23 | 2022 | 7573 | 1.120 |
Why?
|
| Surgical Wound Infection | 2 | 2020 | 450 | 1.110 |
Why?
|
| Maternal Mortality | 3 | 2020 | 77 | 0.990 |
Why?
|
| Obstetrics | 3 | 2022 | 221 | 0.910 |
Why?
|
| Ultrasonography, Prenatal | 3 | 2020 | 830 | 0.820 |
Why?
|
| Delivery, Obstetric | 2 | 2020 | 227 | 0.760 |
Why?
|
| Brachial Plexus | 1 | 2021 | 45 | 0.760 |
Why?
|
| Vaginal Diseases | 1 | 2020 | 26 | 0.730 |
Why?
|
| Equipment Contamination | 1 | 2020 | 90 | 0.720 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 94 | 0.680 |
Why?
|
| Fetal Death | 1 | 2018 | 113 | 0.630 |
Why?
|
| Stillbirth | 1 | 2018 | 82 | 0.630 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 2403 | 0.600 |
Why?
|
| Gestational Age | 4 | 2017 | 1069 | 0.580 |
Why?
|
| Perioperative Care | 1 | 2019 | 451 | 0.520 |
Why?
|
| Uterine Contraction | 1 | 2014 | 31 | 0.500 |
Why?
|
| Uterine Rupture | 1 | 2014 | 21 | 0.500 |
Why?
|
| Pregnancy Outcome | 4 | 2020 | 643 | 0.480 |
Why?
|
| Hospital Mortality | 1 | 2018 | 1274 | 0.430 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 945 | 0.430 |
Why?
|
| Diabetes, Gestational | 1 | 2014 | 104 | 0.430 |
Why?
|
| Guideline Adherence | 1 | 2016 | 636 | 0.420 |
Why?
|
| HELLP Syndrome | 1 | 2010 | 20 | 0.380 |
Why?
|
| Retrospective Studies | 13 | 2022 | 37905 | 0.370 |
Why?
|
| Perinatology | 4 | 2022 | 31 | 0.370 |
Why?
|
| Female | 28 | 2022 | 141928 | 0.360 |
Why?
|
| Retinal Detachment | 1 | 2010 | 88 | 0.360 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2010 | 110 | 0.350 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2010 | 47 | 0.350 |
Why?
|
| Obstetric Labor, Premature | 1 | 2010 | 80 | 0.350 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2008 | 4 | 0.320 |
Why?
|
| Hexokinase | 1 | 2008 | 36 | 0.310 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2008 | 61 | 0.310 |
Why?
|
| Receptors, Leptin | 1 | 2008 | 62 | 0.310 |
Why?
|
| Pre-Eclampsia | 1 | 2010 | 212 | 0.310 |
Why?
|
| Internship and Residency | 1 | 2019 | 1375 | 0.310 |
Why?
|
| Infant, Newborn | 5 | 2020 | 8223 | 0.290 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2010 | 544 | 0.280 |
Why?
|
| Humans | 31 | 2022 | 261506 | 0.270 |
Why?
|
| Parity | 2 | 2017 | 139 | 0.270 |
Why?
|
| Adult | 16 | 2020 | 77950 | 0.270 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 1054 | 0.260 |
Why?
|
| Pregnancy Complications | 2 | 2019 | 526 | 0.240 |
Why?
|
| Spinal Dysraphism | 1 | 2008 | 265 | 0.240 |
Why?
|
| Labor, Obstetric | 3 | 2017 | 86 | 0.210 |
Why?
|
| Cesarean Section, Repeat | 1 | 2021 | 10 | 0.200 |
Why?
|
| Checklist | 1 | 2022 | 122 | 0.200 |
Why?
|
| Postoperative Complications | 1 | 2016 | 5542 | 0.200 |
Why?
|
| Maternal Death | 1 | 2020 | 9 | 0.190 |
Why?
|
| o-Phthalaldehyde | 1 | 2020 | 3 | 0.190 |
Why?
|
| Glutaral | 1 | 2020 | 15 | 0.190 |
Why?
|
| Sterilization | 1 | 2020 | 13 | 0.190 |
Why?
|
| Disposable Equipment | 1 | 2020 | 18 | 0.190 |
Why?
|
| Organizations | 1 | 2020 | 23 | 0.190 |
Why?
|
| Causality | 1 | 2020 | 178 | 0.180 |
Why?
|
| Hemorrhage | 2 | 2022 | 712 | 0.180 |
Why?
|
| Disinfection | 1 | 2020 | 42 | 0.180 |
Why?
|
| Disinfectants | 1 | 2020 | 35 | 0.180 |
Why?
|
| Maternal Health Services | 1 | 2020 | 34 | 0.180 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 1209 | 0.180 |
Why?
|
| Medical Errors | 1 | 2022 | 219 | 0.180 |
Why?
|
| Patient Outcome Assessment | 1 | 2021 | 245 | 0.180 |
Why?
|
| Minority Groups | 1 | 2022 | 322 | 0.180 |
Why?
|
| Healthcare Disparities | 2 | 2022 | 598 | 0.170 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 266 | 0.170 |
Why?
|
| Health Plan Implementation | 1 | 2019 | 90 | 0.170 |
Why?
|
| Live Birth | 1 | 2018 | 56 | 0.160 |
Why?
|
| Morbidity | 1 | 2019 | 397 | 0.160 |
Why?
|
| Term Birth | 1 | 2017 | 30 | 0.160 |
Why?
|
| Infection Control | 1 | 2020 | 270 | 0.160 |
Why?
|
| Attitude | 1 | 2019 | 159 | 0.160 |
Why?
|
| Risk Assessment | 3 | 2020 | 6869 | 0.160 |
Why?
|
| Hospitals | 1 | 2021 | 485 | 0.150 |
Why?
|
| Obstetric Labor Complications | 1 | 2018 | 95 | 0.150 |
Why?
|
| Telemedicine | 1 | 2022 | 471 | 0.140 |
Why?
|
| Oxytocics | 1 | 2016 | 27 | 0.140 |
Why?
|
| Hysterectomy | 1 | 2020 | 611 | 0.140 |
Why?
|
| Oxytocin | 1 | 2016 | 62 | 0.140 |
Why?
|
| Cognition | 1 | 2022 | 968 | 0.140 |
Why?
|
| Young Adult | 7 | 2019 | 21445 | 0.130 |
Why?
|
| Quality of Health Care | 1 | 2020 | 621 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2020 | 2316 | 0.130 |
Why?
|
| Quality Improvement | 1 | 2022 | 851 | 0.130 |
Why?
|
| Risk Factors | 3 | 2020 | 17523 | 0.130 |
Why?
|
| Uncertainty | 1 | 2016 | 320 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2014 | 6100 | 0.120 |
Why?
|
| Patient Safety | 1 | 2020 | 649 | 0.120 |
Why?
|
| Prenatal Care | 2 | 2022 | 325 | 0.120 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2014 | 168 | 0.120 |
Why?
|
| Pregnancy Trimester, First | 1 | 2014 | 127 | 0.120 |
Why?
|
| United States | 5 | 2022 | 15433 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 672 | 0.110 |
Why?
|
| Postpartum Period | 1 | 2014 | 259 | 0.110 |
Why?
|
| Electronic Health Records | 1 | 2020 | 929 | 0.110 |
Why?
|
| Texas | 2 | 2020 | 6311 | 0.110 |
Why?
|
| Fasting | 1 | 2014 | 349 | 0.110 |
Why?
|
| Cohort Studies | 2 | 2016 | 9244 | 0.110 |
Why?
|
| Clinical Protocols | 1 | 2014 | 467 | 0.100 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 980 | 0.100 |
Why?
|
| Logistic Models | 2 | 2019 | 3441 | 0.100 |
Why?
|
| ROC Curve | 1 | 2014 | 1183 | 0.100 |
Why?
|
| Plasmapheresis | 1 | 2010 | 61 | 0.090 |
Why?
|
| Enoxaparin | 1 | 2011 | 66 | 0.090 |
Why?
|
| ADAMTS13 Protein | 1 | 2010 | 92 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2019 | 32848 | 0.090 |
Why?
|
| Surgical Wound Dehiscence | 1 | 2011 | 129 | 0.090 |
Why?
|
| Meningomyelocele | 1 | 2012 | 183 | 0.090 |
Why?
|
| ADAM Proteins | 1 | 2010 | 134 | 0.090 |
Why?
|
| Blood Glucose | 1 | 2014 | 1244 | 0.090 |
Why?
|
| Incidence | 1 | 2019 | 5673 | 0.090 |
Why?
|
| Catalase | 1 | 2008 | 70 | 0.080 |
Why?
|
| Receptor, Insulin | 1 | 2008 | 97 | 0.080 |
Why?
|
| Male | 5 | 2021 | 123000 | 0.070 |
Why?
|
| Leptin | 1 | 2008 | 295 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2008 | 250 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 4971 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 4892 | 0.070 |
Why?
|
| Insurance Coverage | 1 | 2008 | 256 | 0.070 |
Why?
|
| Medicaid | 1 | 2008 | 279 | 0.060 |
Why?
|
| Anticoagulants | 1 | 2011 | 787 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2010 | 2292 | 0.060 |
Why?
|
| Thrombosis | 1 | 2011 | 781 | 0.060 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 3472 | 0.060 |
Why?
|
| Genes, p53 | 1 | 2008 | 1090 | 0.060 |
Why?
|
| Contraception | 1 | 2022 | 49 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2008 | 899 | 0.050 |
Why?
|
| Bias | 1 | 2022 | 205 | 0.050 |
Why?
|
| Social Determinants of Health | 1 | 2022 | 97 | 0.050 |
Why?
|
| Fertilization in Vitro | 1 | 2022 | 199 | 0.050 |
Why?
|
| International Agencies | 1 | 2020 | 107 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2012 | 4549 | 0.050 |
Why?
|
| Genotype | 1 | 2008 | 4109 | 0.040 |
Why?
|
| Maternal Age | 1 | 2019 | 152 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 4314 | 0.040 |
Why?
|
| Fetal Weight | 1 | 2017 | 44 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2022 | 1335 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2008 | 5159 | 0.030 |
Why?
|
| Obesity | 1 | 2008 | 2884 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 5539 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 1225 | 0.030 |
Why?
|
| Comorbidity | 1 | 2019 | 2352 | 0.030 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2012 | 26 | 0.030 |
Why?
|
| Adolescent | 3 | 2019 | 31252 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2019 | 4298 | 0.030 |
Why?
|
| Prevalence | 1 | 2019 | 3260 | 0.030 |
Why?
|
| Puerperal Disorders | 1 | 2011 | 41 | 0.020 |
Why?
|
| Hospitalization | 1 | 2019 | 2083 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 4320 | 0.020 |
Why?
|
| Family | 1 | 2012 | 736 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2012 | 1084 | 0.020 |
Why?
|
| Middle Aged | 3 | 2019 | 86204 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 12926 | 0.010 |
Why?
|
| Infant | 1 | 2012 | 13310 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2012 | 16273 | 0.010 |
Why?
|
| Child | 1 | 2012 | 29154 | 0.010 |
Why?
|